Mar 8, 2016 9:23 am EST Abeona Therapeutics Announces Fourth Quarter and Full Year 2015 Summary Financial Results and Recent Operational Highlights
Mar 2, 2016 8:19 am EST Abeona Therapeutics Highlights New Preclinical Juvenile Neuronal Ceroid Lipofuscinosis (JNCL) Data at WORLDSymposium(TM) 2016
Feb 29, 2016 7:03 am EST Abeona Therapeutics Announces FDA Allowance of Investigational New Drug (IND) for Systemic AAV Phase 1/2 Clinical Study With ABO-102 Gene Therapy for Patients With Sanfilippo Syndrome Type A (MPS IIIA)
Feb 24, 2016 9:36 am EST Abeona Therapeutics, Inc. to Present on CRISPR/CAS9 Technology Platform Progress at CRISPR Precision Gene Editing Congress
Feb 9, 2016 9:17 am EST Abeona Therapeutics to Present at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference
Feb 4, 2016 9:28 am EST Abeona Therapeutics to Present at the 18th Annual BIO CEO & Investor Conference
Jan 11, 2016 9:03 am EST Abeona Therapeutics Announces Initial European Regulatory Approvals for Phase 1/2 Gene Therapy Clinical Studies for Patients With Sanfilippo Syndromes Type A (MPS IIIA) and Type B (MPS IIIB)
Dec 1, 2015 9:03 am EST Abeona Therapeutics to Present at Piper Jaffray 27th Annual Healthcare Conference
Nov 18, 2015 9:03 am EST Abeona Therapeutics to Present at Jefferies 2015 Global Healthcare Conference
Nov 17, 2015 9:03 am EST Abeona Therapeutics Reports Financial Results and Highlights for Third Quarter 2015
